CRP and metabolic dysfunction-associated steatotic liver disease: Global literature demonstrates a strong correlation between hepatic biomarkers in NAFLD and non-hepatic indicators such as C-reactive protein (CRP), HOMA-IR, and triglyceride, signifying systemic inflammation, insulin resistance, and metabolic dysfunction associated with NAFLD progression and severity [9-11].